UCB Japan Co. Ltd.

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Subsidiary

Established: 1988-04-28

Employees: 501

Market Cap: -

Website: http://www.ucbjapan.com

Clinical Trials

A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Phase 3

Completed

Conditions: Partial Seizures

Interventions: Drug: Levetiracetam

First Posted Date: 2017-11-13

Last Posted Date: 2024-07-23

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 38

Registration Number: NCT03340064

Locations: 🇯🇵
Ep0100 20, Kobe, Japan
🇯🇵
EP0100 3, Hamamatsu, Japan
🇯🇵
Ep0100 15, Fukuoka, Japan

and more 18 locations

Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures

Phase 3

Completed

Conditions: Partial-onset Seizures
Epilepsy

Interventions: Drug: Lacosamide (200 mg/20 mL)

First Posted Date: 2014-07-17

Last Posted Date: 2017-08-25

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 9

Registration Number: NCT02192814

Locations: 🇯🇵
81025, Sapporo, Japan
🇯🇵
81027, Hamamatsu, Japan
🇯🇵
81003, Shizuoka, Japan

and more 2 locations

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Phase 3

Completed

Conditions: Epilepsy
Partial-onset Seizures

Interventions: Drug: Lacosamide

First Posted Date: 2014-04-28

Last Posted Date: 2019-10-28

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 19

Registration Number: NCT02124564

Locations: 🇯🇵
6, Kagoshima, Japan
🇯🇵
7, Kamakura, Japan
🇯🇵
11, Itami, Japan

and more 8 locations

Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Multiple 15-minute intravenous infusions of 1500 mg levetiracetam

First Posted Date: 2012-11-12

Last Posted Date: 2013-03-29

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 32

Registration Number: NCT01725009

Locations: 🇯🇵
01, Tokyo, Japan

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Phase 3

Completed

Conditions: Epilepsy
Partial Onset Seizures

Interventions: Drug: Levetiracetam (LEV)

First Posted Date: 2012-01-10

Last Posted Date: 2015-12-31

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 71

Registration Number: NCT01506882

Locations: 🇯🇵
8, Kagoshima, Japan
🇯🇵
21, Daito, Japan
🇯🇵
33, Asaka, Japan

and more 24 locations

Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Phase 2

Completed

Conditions: Rheumatoid Arthritis

Interventions: Biological: Placebo
Biological: Olokizumab 60 mg
Biological: Olokizumab 120 mg
Biological: Olokizumab 240 mg

First Posted Date: 2011-11-01

Last Posted Date: 2013-03-25

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 119

Registration Number: NCT01463059

Locations: 🇰🇷
203, Seoul, Korea, Republic of
🇰🇷
204, Seoul, Korea, Republic of
🇯🇵
114, Fukuoka, Japan

and more 36 locations

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Phase 2

Completed

Conditions: Epilepsy
Partial Onset Seizures

Interventions: Drug: Levetiracetam

First Posted Date: 2011-08-02

Last Posted Date: 2013-03-07

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 16

Registration Number: NCT01407523

Locations: 🇯🇵
1, Niigata-city, Niigata, Japan
🇯🇵
2, Shizuoka-city, Shizuoka, Japan
🇯🇵
3, Kodaira-city, Tokyo, Japan

and more 1 locations

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Phase 3

Completed

Conditions: Generalized Tonic-clonic Seizures
Epilepsy

Interventions: Drug: Levetiracetam

First Posted Date: 2011-02-10

Last Posted Date: 2015-05-15

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 13

Registration Number: NCT01292837

Locations: 🇯🇵
184, Bunkyo, Japan
🇯🇵
303, Hiroshima, Japan
🇯🇵
309, Bunkyo, Japan

and more 23 locations

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Phase 3

Completed

Conditions: Epilepsy
Generalized Tonic-Clonic Seizures

Interventions: Drug: Placebo
Drug: Levetiracetam

First Posted Date: 2010-10-26

Last Posted Date: 2019-01-15

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 361

Registration Number: NCT01228747

Locations: 🇯🇵
152, Fujisawa, Japan
🇯🇵
170, Saito, Japan
🇯🇵
153, Kashiwakazi, Japan

and more 55 locations

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Phase 3

Completed

Conditions: Partial Seizures
Epilepsy

Interventions: Drug: Levetiracetam

First Posted Date: 2010-02-05

Last Posted Date: 2015-03-05

Lead Sponsor: UCB Japan Co. Ltd.

Target Recruit Count: 73

Registration Number: NCT01063764

Locations: 🇯🇵
10, Koushi, Japan
🇯🇵
31, Kurume, Japan
🇯🇵
8, Neyagawa, Japan

and more 26 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy